Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02386501 |
| Title | Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Advaxis, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Not Yet Recruiting | Los Angeles | California | United States | Details | ||
| Site | Aurora | Colorado | United States | Details | ||
| Grand Rapids | Michigan | United States | Details | |||
| Site | Charlotte | North Carolina | United States | Details | ||
| Site | Philadelphia | Pennsylvania | United States | Details | ||
| Dallas | Texas | United States | Details |